Protective effect of alprazolam against sleep deprivation-induced behavior alterations and oxidative damage in mice

Neuroscience Research

Volumn 60, Issue 4, 2008, Pages 372-379

  Singh, Anant ^a   Kumar, Anil ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Alprazolam; Ambulatory movements; Anxiety; Oxidative damage; Sleep deprivation

Indexed keywords

ALPRAZOLAM; FLUMAZENIL; MUSCIMOL; PICROTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DRUG EFFECT; LIPID PEROXIDATION; LOW DRUG DOSE; MALE; MAZE TEST; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SLEEP DEPRIVATION;

ALPRAZOLAM; ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BEHAVIORAL SYMPTOMS; BODY WEIGHT; BRAIN CHEMISTRY; CATALASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GABA AGENTS; GLUTATHIONE; LIPID PEROXIDATION; MALE; MAZE LEARNING; MICE; MOVEMENT; NITRITES; OXIDATIVE STRESS; SLEEP DEPRIVATION;

EID: 40649121958     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2007.12.003     Document Type: Article

References (50)

1. Bergmann B.M., Everson C.A., Kushida C.A., Fang V.S., Leitch C.A., Schoeller D.A., Refetoff S., and Rechtschaffen A. Sleep deprivation in the rat. V. Energy use and mediation. Sleep 12 (1989) 31-41
2. Biggio G., Concas A., Serra M., Salis M., Corda M.G., Nurchi V., Crisponi C., and Gessa G.L. Stress and b-carbolines decrease the density of low-affinity GABA binding sites: an effect reversed by diazepam. Brain Res. 305 (1984) 13-18
3. Bristow D.J., and Holmes D.S. Cortisol levels and anxiety related behaviors in cattle. Physiol. Behav. 90 (2007) 626-628
4. Bueno O.F., Oliveira G.M., Lobo L.L., Morais P.R., Melo F.H., and Tufik S. Cholinergic modulation of inhibitory avoidance impairment induced by paradoxical sleep deprivation. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 24 (2000) 595-606
5. Chouniard G., Beauclair L., and Belanger M.C. Gabapentin: long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders. Can. J. Psychiatry 43 (1998) 305
6. Cirelli C. Cellular consequences of sleep deprivation in the brain. Sleep Med. Rev. 10 (2006) 307-321
7. Dalvi A., and Rodgers R.J. Anxiolytic effects of valproate and diazepam in mice are differentially sensitive to picrotoxin antagonism. Pharmacol. Biochem. Behav. 68 (2004) 23-32
8. Dawson S.G., Jue R.N., and Brogden R.N. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression. Drugs 27 (1984) 132-147
9. Dombrowski P.A., Fernandes L.H., and Andreatini R. Picrotoxin blocks the anxiolytic- and panicolytic-like effects of sodium valproate in the rat elevated T-maze. Eur. J. Pharmacol. 10 (2006) 72-76
10. Dringen R., Pawlowski P.J., and Hirrlinger J. Peroxide detoxification by brain cells. J. Neurosci. Res. 79 (2005) 157-165
11. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82 486 (1959) 70-77
12. Farooqui S.M., Brock J.W., and Zhou J. Changes in monoamines and their metabolite concentrations in REM sleep-deprived rat forebrain nuclei. Pharmacol. Biochem. Behav. 54 (1996) 385-391
13. Giordano R., Pellegrino M., Picu A., Bonelli L., Balbo M., Berardelli R., Fabio L., and Ezio G. Neuroregulation of the hypothalamus-pituitary-adrenal (HPA) axis in humans: effects of GABA-, mineral corticoid-, and GH-secretagogue-receptor modulation. Sci. World J. 17 (2006) 1-11
14. Gopalakrishnan A., Ji L.L., and Cirelli C. Sleep deprivation and cellular responses to oxidative stress. Sleep 27 (2004) 27-35
15. Goyal R., and Kumar A. Protective effect of alprazolam in acute immobilization stress-induced certain behavioral and biochemical alterations in mice. Pharmacol. Rep. 59 (2007) 284-290
16. Green L.C., Wagner D.A., and Glagowski J. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal. Biochem. 126 (1982) 131-138
17. Halliwell B., Gutteridge J.H.C., and Cross C.E. Free radicals, antioxidants and human disease: where we are now?. J. Lab. Clin. Med. 119 (1992) 598-620
18. Hashem A.A., Claffey N.M., and O'Connell B. Pain and anxiety following the placement of dental implants. Int. J. Oral Maxillofac. Implants 21 (2006) 943-950
19. Kalonia H., and Kumar A. Protective effect of melatonin on certain behavioral and biochemical alterations induced by sleep-deprivation in mice. Indian J. Pharmacol. 39 (2007) 48-51
20. Knutson L.K., Spiegel K., Penev P., and Cauter E.V. The metabolic consequences of sleep deprivation. Sleep Med. Rev. 11 3 (2007) 163-178
21. Kulkarni S.K. Hand Book of Experimental Pharmacology. third ed. (1999), Vallabh prakashan, Delhi pp. 117-118
22. Kulkarni S.K., and Reddy D.S. Animal behavioral models for testing antianxiety agents. Methods Find. Exp. Clin. Pharmacol. 18 (1996) 219-230
23. Kumar A., and Kalonia H. Protective effect of Withania somnifera Dunal on the behavioral and biochemical alterations in sleep-disturbed mice (grid over water suspended method). Indian J. Exp. Biol. 45 6 (2007) 524-528
24. Kumar A., and Kulkarni S.K. Effect of herbals on sleep and their interactions with hypnotic drugs. Indian J. Pharmacol. Sci. 67 (2005) 391-393
25. Laney P.H., Levy J.A., and Kipp D.E. Plasma cortisol and adrenal ascorbic acid levels after ACTH treatment with a high intake of ascorbic acid in the guinea pig. Ann. Nutr. Metab. 34 (1990) 85-92
26. Lowry O.H., Rosenberg N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 193 (1951) 265-275
27. Luck H. In: Bergmeyer H.U. (Ed). Methods of Enzymatic Analysis (1971), Academic Press, New York 885-893
28. Mcewen B.S. Sleep deprivation as a neurobiologic and physiologic stressor: allostasis and allostatic load. Metabolism 55 (2006) S20-S23
29. Molodavkin G.M., Voronina T.A., Aldarmaa Z.H., and Meletova O.K. Stress-induced alteration of the antiaggressive effect of anxiolytics. Eksp Klin Farmakol 67 (2004) 3-6
30. Mombereau C., Kaupmann K., Froestl W., Sansig G., Putten V.H., and Cryan J.F. Genetic and Pharmacological evidence of a role for GABAB receptors in the modulation of anxiety and antidepressant like behavior. Neuropsychopharmacology 29 (2004) 1050-1062
31. Moreira T. Sleep, health and the dynamics of biomedicine. Soc. Sci. Med. 63 1 (2006) 54-63
32. O'Connor T.M., O'Halloran D.J., and Shanahan F. The stress response and the hypothalamo-pituitary- adrenocortical axis: from molecule to melancholia. Q. J. Med. 93 (2000) 323-333
33. Obermeyer W., Bergmann B.M., and Rechtschaffen A. Sleep deprivation in the rat. XIV. Comparison of waking hypothalamic and peritoneal temperatures. Sleep 14 (1991) 285-293
34. Paredes R.G., and Agmo A. GABA and behavior: the role of receptor subtypes. Neurosci. Biobehav. Rev. 16 (1992) 145-170
35. Rabow L.E., Russek S.J., and Farb D.H. From ion currents to genomic analysis: recent advances in GABAA receptor research. Synapse 21 (1995) 189-274
36. Rajaratnam S.M.W., and Arendt J. Health in a 24-h society. Lancet 358 (2001) 999-1005
37. Ramananthan L., Gulayani S., Nienhuis R., and Siegel J.M. Sleep deprivation decreases superoxide dismutase activity in rat hippocampus and brainstem. Neuroreport 11 (2002) 1387-1390
38. Reddy D.S., and Kulkarni S.K. Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging and dizocilpine-induced learning impairment. Brain Res. 799 (1998) 215-229
39. Rial V.R., Nicolau C.M., Gamundí A., Akaârir M., Aparicio S., Garau C., Tejada S., Roca C., Gene L., Moranto D., and Esteban S. The trivial function of sleep. Sleep Med. Rev. 11 4 (2007) 311-325
40. Sei H., Saitoh D., Yamamoto K., Morita K., and Morita Y. Differential effect of short-term REM sleep deprivation on NGF and BDNF protein levels in the rat brain. Brain Res. 877 (2000) 387-390
41. Shaw P.J., Bergmann B.M., and Rechtschaffen A. Effects of paradoxical sleep deprivation on thermoregulation in the rat. Sleep 21 (1998) 7-17
42. Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., and Dourish C.T. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology 116 (1994) 56-64
43. Sherki Y.G., Melemed E., and Offen D. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40 (2001) 959-975
44. Shinomiya K., Shigemoto Y., Okuma C., Mio M., and Kamei C. Effects of short-acting hypnotics on sleep latency in rats placed on grid suspended over water. Eur. J. Pharmacol. 460 (2003) 139-144
45. Steiger A. Neurochemical regulation of sleep. J. Psychiatr. Res. 41 7 (2007) 537-552
46. Suchecki D., Tiba P.A., and Tufik S. Hormonal and behavioral responses of paradoxical sleep-deprived rats to the elevated plus maze. J. Neuroendocrinol. 14 (2002) 549-554
47. Verster J.C., and Volkerts E.R. Cinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of literature. CNS Drug Rev. 149 (2004) 176-180
48. Weizman R., Weizman A., Kook K.A., Vocci F., Deutsch S.I., and Paul S.M. Repeated swim stress alters brain benzodiazepine receptors measures in vivo. J. Pharmacol. Exp. Ther. 340 (1990) 701-707
49. Wills E.D. Mechanism of lipid peroxide formation in animal tissues. Biochem. J. 99 (1966) 667-676
50. Yourn A.B., and Chu D. Distribution of GABAA and GABAB receptors in the mammalian brain. Drug Dev. Res. 21 (1990) 161